# CRITIC_PJST_D1_CYCLE3_LINUX_GATE_RECHECK-v001

- You are the independent Critic final focused recheck for PJST-D1 Cycle-3.
- Review read-only exact clean commit `a16a67c4f74ce19de640704c357850c0e7b85ba3` in `C:/Users/skywalker/.codex/worktrees/duca-pjst-cycle3-builder-20260826`.
- Parent: `cbefa51563adce5c512403695259f2fcb3da16fa`.
- Read the Evaluator receipt `E:/DeskTop/TAD/OpenTAD_C3_CoarseClean_20260702/.cvpr-pro-lab/role-returns/EVALUATOR_PJST_D1_CYCLE3_N16R4_PRERUN-v001.md` and Builder return `E:/DeskTop/TAD/OpenTAD_C3_CoarseClean_20260702/.cvpr-pro-lab/role-returns/BUILDER_PJST_D1_CYCLE3_LINUX_GATE_CORRECTION-v001.md`.
- No edits/commits/browser/data/GPU/Slurm/remote/training/inference/evaluation/metric.

Verify:

1. Diff is exactly `opentad/models/utils/temporal_grid.py` and `tests/test_duca_pjst_d1_derivative_only.py`; no other scope.
2. Pair mask is exactly five-dimensional and broadcasts over `[Bclips,3,8,H,W]`; valid-pair formula/gradient/dtype are preserved and uniform/invalid pairs retain identity.
3. Detector tests correctly initialize `nn.Module` but still exercise production `_call_backbone` and `forward_train` paths.
4. Remap test isolates `SingleStageDetector.post_processing`, counts the actual `self.` call exactly once, and proves it precedes threshold/top-k/NMS; it does not hide a real production duplicate.
5. No previous checkpoint/config/launcher fix regressed. Run useful static checks and focused pytest if Torch imports; never count a Windows skip as PASS.

Return `PJST_D1_FOCUSED_STATIC_PASS` if the three exact Linux failures are correctly closed in code and ready for Evaluator N16R4 rerun; otherwise `BLOCKED_PRE_RUN` with exact deterministic defects. Since this is the final focused correction of this cycle, any equivalent remaining defect terminates the implementation package rather than authorizing another patch.

Write `E:/DeskTop/TAD/OpenTAD_C3_CoarseClean_20260702/.cvpr-pro-lab/role-returns/CRITIC_PJST_D1_CYCLE3_LINUX_GATE_RECHECK-v001.md` with commit/cleanliness/diff/evidence/commands/verdict/next_owner. No efficacy claim.
